City

Dallas (1)

Philadelphia (1)

Condition

Metastatic Anaplastic Thyroid Cancer (2)

Locally Advanced Anaplastic, Undifferentiated Thyroid Cancer (1)

Metastatic Differentiated Thyroid Cancer (1)

Metastatic Medullary Thyroid Cancer (1)

Metastatic Poorly Differentiated Thyroid Cancer (1)

Overall Status

Completed (1)

Withdrawn (1)

Sign in for free

Phase

phase 2 (2)

Sponsor

University of Pennsylvania (1)

University of Texas Southwestern Medical Center (1)

Collaborator

Novartis (1)

Intervention

ceritinib (1)

sorafenib (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (2)

Study Type

Interventional (2)

metastatic anaplastic thyroid cancer

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Metastatic Differentiated Thyroid Cancer, Metastatic Poorly Differentiated Thyroid Cancer, Metastatic Anaplastic Thyroid Cancer

Completed

Metastatic Differentiated Thyroid Cancer
+3 more

sorafenib

Philadelphia, Pennsylvania

University of Pennsylvania - Abramson Comprehensive Cancer Cente

Nov 13, 2019

Metastatic Anaplastic Thyroid Cancer, Locally Advanced Anaplastic, Undifferentiated Thyroid Cancer Trial in Dallas (Ceritinib)

Withdrawn

Metastatic Anaplastic Thyroid Cancer
Locally Advanced Anaplastic, Undifferentiated Thyroid Cancer

Ceritinib

Dallas, Texas

UT Southwestern Medical Center

Jul 26, 2019